AstraZeneca after the huge anti -cancer scandal in China is returning dynamically to the Chinese market, selling a medicine for cancer. Last year, the United Kingdom-based pharmaceutical group entered into judicial adventures-it is still ongoing-when Local Manager Leon Wang was arrested in October for illegal drug sales. According to the indictment, Wang did not pay tax on certain anti -cancer drugs, including IMFinzi (Durvalumab) and Imjudo (Tremelimumab). Also, along with former Astrazeneca oncology in China, they were charged with illegal introduction and sale of Imjudo through Hong Kong. Since the scandal broke out, sales have fallen 10% and CEO Pascal Soriot has visited the country many times to settle the problem. Among other things he met privately, but also officially with Chinese President Xi Jinping, arranging a meeting of Chinese officials with group officials. Soriot then replaced Leon Wang with experienced Iskra Reic executive and invested 2.5 billion […]
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
